Pracinostat and Azacitidine vs. Hu5F9-G4 in Combination With Azacitidine
- This topic has 0 replies, 1 voice, and was last updated 5 years, 10 months ago by
.
Viewing 1 post (of 1 total)
-
Hi, I am considering two of the above clinical trials to treat RAEB-2 (17% blasts) with Monosomy 7 and 4 other mutations. We have not yet begun any treatment.
Monosomy 7 has shown promise with Azacitidine (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936359/), but I am wondering if anyone has an opinion on the two experimental drugs Pracinostat vs. Hu5F9-G4. The trials are at two different locations and will determine where we are treated.
Trial Numbers:
Pracinostat – NCT03151304
Hu5F9-G4 – NCT03248479Thanks!
-
This topic was modified 5 years, 10 months ago by
-
This topic was modified 5 years, 10 months ago by
Viewing 1 post (of 1 total)
Register for an account, or login to post to our message boards. Click here.
- You must be logged in to reply to this topic.
